A new SARS-Cov-2 vaccine that prevents cross-reactivity development is in the offing. This is being carried out by…
CEPI will provide funding of up to US$19.3 million to support the development of a ‘variant-proof’ SARS-CoV-2 vaccine…
Science pays, if you are passionate, and committed towards it, COVAXIN Scientist Krishna Ella said. Addressing young entrepreneurs…
New Delhi: Launching Dr Jacob John authored Book on POLIO - The Eradication Imgroglio in New Delhi on…
BHARAT BIOTECH and BIOFABRI announced today their partnership to develop, manufacture and distribute a novel TB vaccine, MTBVAC.…
Hyderabad: COVAXIN maker Bharat Biotech is on the verge of developing a vaccine against tuberculosis and soon the…
Telangana District Court directed The Wire to remove 14 articles it published by it that were critical of…
COVAXIN Shelf Life, what is it, need to be understood clearly, which all parents and their children ought…
Developing India's first indigenous Vaccine COVAXIN under 10 months was a tremendous challenge. Bharat Biotech Director, V Krishna…
The Central Drugs Standard Control Organisation (CDSCO) has approved the extension of Covid-19 vaccine Covaxin Shelf Life to…
COVAXIN The Success of India's Indigenous COVID-19 Vaccine developed by Bharat Biotech in partnership with ICMR and NIV…
Bharat Biotech Typhoid Vaccine ( a Conjugate Vaccine ) Typbar TCV that averts typhoid fever, caused by a…
Sign in to your account